AMH (anti-Müllerian hormone) is used clinically as a marker of ovarian reserve, but its utility for fertility prediction is limited. It correlates with the number of remaining eggs but does not reliably predict natural conception or IVF success. Levels fluctuate during the menstrual cycle and decline with age. A low AMH does not mean infertility, and a high AMH does not guarantee pregnancy. Evidence comes from clinical studies and guidelines (e.g., ESHRE), but it is insufficient for standalone prognosis. For fertility counseling, AMH should be interpreted alongside age, cycle characteristics, and partner factors. Direct-to-consumer AMH tests often lack standardization and may lead to misinterpretation. The evidence level is moderate, not diagnostic.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-4ecbe6dc5f31f28333f9e872